Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

[1]  J. Egan,et al.  Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. , 2001, Transplantation.

[2]  K. Goa,et al.  Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. , 2001, Drugs.

[3]  C. Sabin,et al.  Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation , 2000, The Lancet.

[4]  R. Storb,et al.  Mini-allografts: ongoing trials in humans , 2000, Bone Marrow Transplantation.

[5]  J. Tarrand,et al.  Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  H. Kuroda,et al.  Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients. , 1999, International journal of hematology.

[7]  A. Humar,et al.  The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation , 1999, Bone Marrow Transplantation.

[8]  R. Fanin,et al.  Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. , 1999, Haematologica.

[9]  P. Ljungman,et al.  Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. , 1998, Transplantation.

[10]  S. Brunet,et al.  Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience , 1998, Bone Marrow Transplantation.

[11]  E J Freireich,et al.  Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. , 1998, Blood.

[12]  J. Szer,et al.  Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine , 1998, Bone Marrow Transplantation.

[13]  Y. Yazaki,et al.  Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation. , 1998, British journal of haematology.

[14]  M. Boeckh,et al.  Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome. , 1997, Blood.

[15]  M. Boeckh,et al.  Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. , 1997, Transplantation.

[16]  D. Catovsky,et al.  Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia , 1997, British journal of haematology.

[17]  P. Griffiths.  Prophylaxis against CMV infection in transplant patients. , 1997, The Journal of antimicrobial chemotherapy.

[18]  K. St. George,et al.  Prevention of CMV disease in allogeneic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy. , 1997, Journal of pediatric hematology/oncology.

[19]  H. Prentice,et al.  Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant , 1997, Bone Marrow Transplantation.

[20]  T. Bechtel,et al.  Cytomegalovirus Prophylaxis and Treatment following Bone Marrow Transplantation , 1996, The Annals of pharmacotherapy.

[21]  N. Milpied.  Prophylaxis of cytomegalovirus infection in bone marrow transplant patients. , 1996, International journal of antimicrobial agents.

[22]  M. Dyer,et al.  Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemia , 1996, British journal of haematology.

[23]  Forman Sj,et al.  Cytomegalovirus infection in the bone marrow transplant recipient. , 1995 .

[24]  C. S. Campbell,et al.  Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. , 1995, Thorax.